Jianguo Yang
Abpro, China
Biography
Dr. Jianguo Yang, is the CEO of Abpro, China and Vice President Abpro, USA. He was the principal scientist , leads late stage biologics commercial projects at Genzyme/ Sanofi. Prior to Genzyme, he worked on early, late stage and commercial biologic drug development in MedImmune /Astrazeneca and Abbott labs , respectively . With over 16-year bio-pharm industry experience, and achieved world record high mammalian cell line productivity, he is an international recognized expert in biologics development, and frequently invited keynote speaker / chairperson / scientific advisor for international conferences, a member of Editor and Advisor Board for Bioprocess International Journal, reviewer for scientific and professional Journals, and authored numerous publications and patent applications. He holds both M.S. and Ph.D. degrees in molecular cell biology and biotechnology from Illinois Institute of Technology.
Abstract
Abstract : Globalization Of Biosimilars